Assessment of minimum inhibitory concentration to vancomycin, tigecycline, linezolid, daptomycin, ceftaroline and mupirocin against methicillin resistant Staphylococcus aureus clinical isolates by antibiotic gradient strips

Authors

  • Aparna N. Department of Medical Microbiology, School of Medical Education, Centre for Professional and Advanced Studies, Kottayam, Kerala, India
  • Devipriya P. R. Department of Medical Microbiology, School of Medical Education, Centre for Professional and Advanced Studies, Kottayam, Kerala, India
  • Shilpa N. Department of Medical Microbiology, School of Medical Education, Centre for Professional and Advanced Studies, Kottayam, Kerala, India
  • Fashna Premanandan Department of Medical Microbiology, School of Medical Education, Centre for Professional and Advanced Studies, Kottayam, Kerala, India
  • Anusree K. B. Department of Medical Microbiology, School of Medical Education, Centre for Professional and Advanced Studies, Kottayam, Kerala, India
  • Saliha Sathar Department of Medical Microbiology, School of Medical Education, Centre for Professional and Advanced Studies, Kottayam, Kerala, India
  • Harish Kumar K. S. Department of Medical Microbiology, School of Medical Education, Centre for Professional and Advanced Studies, Kottayam, Kerala, India

DOI:

https://doi.org/10.18203/2319-2003.ijbcp20240380

Keywords:

MRSA, Minimum inhibitory concentration, Multidrug resistance, Anti-MRSA drugs, Decolonization

Abstract

Background: Staphylococcus aureus infections are one of the most common and serious hospital-acquired infections seen in developing countries. Methicillin resistant Staphylococcus aureus (MRSA) is an important human pathogen and normally colonized in body parts including skin, nose, perineum and throat. MRSA is resistant not only to all β-lactam groups but also other antibiotics including aminoglycosides, tetracycline and macrolides. In the present study the efficacy of agents used in the management of MRSA infections was determined by antibiotic gradient testing.

Methods: A total of 60 clinical isolates of MRSA strains were collected from various diagnostic labs in central Kerala. Clinical isolates were reconfirmed as MRSA by gram staining, yellow-coloured colonies on mannitol salt Agar (MSA). Antibiotic susceptibility testing was done by disc diffusion method as recommended by CLSI guidelines. S. aureus isolates resistant to cefoxitin (30 µg) was identified as MRSA. Antibiotic gradient testing was performed to determine the MIC of vancomycin, tigecycline, linezolid, daptomycin, ceftaroline and mupirocin against MRSA isolates.

Results: All the 60 MRSA isolates tested were sensitive to vancomycin, tigecycline, linezolid, daptomycin, ceftaroline and mupirocin (100%) and none of the MRSA isolates show resistance. 

Conclusions: Results of present study indicates that these agents may be used alongside vancomycin in management of infection caused by MRSA.

References

Yilmaz G, Aydin K, Iskender S, Caylan R, Koksal I. Detection and prevalence of inducible clindamycin resistance in Staphylococci. J Med Microbiol. 2007;56(pt3):342-5.

Wertheim H, Melles D, Vos M, Willem VL, Alex VB, Henri AV et al. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis. 2005;5(12):751-62.

Bitrus AA, Peter OM, Abbas MA, Goni MD. Staphylococcus aureus: A Review of Antimicrobial Resistance Mechanisms. Veterinary Sci Res Rev. 2018;4(2).

DeLeo FR, Chambers HF. Reemergence of antibiotic-resistant Staphylococcus aureus in the genomics era. J Clin Investig. 2009;119(9):2464-74.

Durai R, Ng PC, Hoque H. Methicillin-resistant Staphylococcus aureus: an update. AORN J. 2010;91(5):599-606.

Jevons MP. “Celbenin” resistant Staphylococci. Br Med J. 1961;1(5219):124-5.

Katayama Y, Ito T, Hiramatsu K. A new class of genetic element, staphylococcus cassette chromosome mec, encodes methicillin resistance in Staphylococcus aureus. Antimicrob Agents Chemother. 2000;44(6):1549-55.

Grubb WB. Genetics of MRSA. Rev Med Microbiol. 1998;9:153-62.

Chambers HF, DeLeo FR. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat Rev. 2009;7:629-641

Chang S, Sievert DM, Hageman JC, Matthew LB, Fred CT, Frances PD et al. Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N Engl J Med. 2003;348(14):1342-7.

Rodvold KA, McConeghy KW. Methicillin-resistant Staphylococcus aureus therapy: Past, present, and future. Clin Infect Dis. 2014;58(1):S20-7.

Hogue JS, Buttke P, Braun LE, Fairchok MP. Mupirocin resistance related to increasing mupirocin use in clinical isolates of methicillin-resistant Staphylococcus aureus in a pediatric population. J Clin Microbiol. 2010;48(7):2599-600.

Yanagisawa T, Lee JT, Wu HC, Kawakami M. Relationship of protein structure of isoleucyl-tRNA synthetase with pseudomonic acid resistance of Escherichia coli. A proposed mode of action of pseudomonic acid as an inhibitor of isoleucyl-tRNA synthetase. J Biol Chem. 1994;269(39):24304-9.

M100- Performance standards for Antimicrobial Susceptibility Tests, 32nd Edition. Clinical Laboratory Standards Institute. 2022.

M02-Performance standards for Antimicrobial Disk Susceptibility Tests, 13th Edition. Clinical Laboratory Standards Institute. 2021.

Ketaki VK, Sandhya K, Niranjan P. Evaluation of Vancomycin Mic Creep Phenomenon in MRSA Isolates from Clinical Samples. Int J Recent Sci Res. 2020;11(03):37797-800.

Swarupa R, Tejashree A, Ranjitha SG, Krishna KMVS, Eeshita D, Satya BS et al Comparative evaluation of MIC of Vancomycin among methicillin resistant Staphylococcus aureus (MRSA) isolates in tertiary care hospital. 2022;13(4):308-12.

Anitha TK, Morubagal RR, Ranjitha S, Rashmi PM, Sowmya GS, Vidyavathi BC. Evaluation of Vancomycin Minimum Inhibitory Concentration in the clinical isolates of Methicillin Resistant Staphylococcus aureus (MRSA). J Pure Appl Microbiol. 2019;13(3):1797-801.

Sattar A, Abbasi SA, Faqir F, Mirza IA, Usman J, Faraz A. Antimicrobial activity of tigecycline against methicillin resistant Staphylococcus aureus in a tertiary care setting. Pak Armed Forces Med J. 2011;61:111-3.

Çomoğlu Ş. Determination of In vitro Activity of Linezolid in Resistance Gram Positive Bacteria by E-Test Method. Haydarpasa Numune Training Res Hospital Med J. 2018;59(1):25-30.

Chitnis S, Katara G, Hemvani N, Pareek S, Chitnis DS. In vitro activity of daptomycin and linezolid against methicillin resistant Staphylococcus aureus and vancomycin resistant Enterococci isolated from hospitalized cases in Central India. Indian J Med Res. 2013;137(1):191-6.

Husain A, Rawat V, Umesh, Kumar M, Verma PK. Vancomycin, linezolid and daptomycin susceptibility pattern among clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA) from Sub- Himalyan Center. J Lab Physicians. 2018;10(2):145-8.

Shivanna V, Prajwal SS, Venkatesha D. Ceftaroline In-vitro Activity against Methicillin Resistant Staphylococcal Isolates in a Rural Tertiary Healthcare Centre. 2021;10(2):MO24-7.

Mushtaq S, Farhana A, Khan S. In vitro Activity of Ceftaroline against methicillin resistant Staphylococcus aureus (MRSA) isolates from different clinical samples: A study from a tertiary care hospital. JMS. 2021;24(4):12-7.

Rajkumari N, Mathur P, Bhardwaj N, Gupta G, Dahiya R, Behera B et al. Resistance pattern of mupirocin in methicillin-resistant Staphylococcus aureus in trauma patients and comparison between disc diffusion and E-test for better detection of resistance in low resource countries. J Lab Physicians. 2014;6(2):91-5.

Downloads

Published

2024-02-23

How to Cite

N., A., P. R., D., N., S., Premanandan, F., K. B., A., Sathar, S., & Kumar K. S., H. (2024). Assessment of minimum inhibitory concentration to vancomycin, tigecycline, linezolid, daptomycin, ceftaroline and mupirocin against methicillin resistant Staphylococcus aureus clinical isolates by antibiotic gradient strips. International Journal of Basic & Clinical Pharmacology, 13(2), 245–249. https://doi.org/10.18203/2319-2003.ijbcp20240380

Issue

Section

Original Research Articles